Table 6:
PGIS Promoter VNTR, SNP3, and SNP4 Genotype Association with PAH Risk
| Odds Ratio | 95% CI | Chi-Square Test | P Value | |
|---|---|---|---|---|
| SNP1 K22 Genotypes*† | ||||
| G/T vs. G/G | 0.85 | 0.42–1.72 | 0.21 | ns |
| T/T vs. G/G | 0.52 | 0.24–1.11 | 2.87 | 0.090 |
| SNP3 Y185 Genotypes*† | ||||
| C/T vs C/C | 1.11 | 0.60–2.04 | 0.12 | ns |
| T/T vs C/C | 0.40 | 0.18–0.87 | 5.40 | 0.020 |
| SNP4 C325A Genotypes*‡ | ||||
| C/A+A/A vs C/C | 0.27 | 0.10–0.72 | 7.36 | 0.007 |
Definition of abbreviations: CI = confidence interval; ns = not significant; PAH = pulmonary arterial hypertension; PGIS = prostacyclin synthase; SNP = single-nucleotide polymorphism; VNTR = variable number of tandem repeats.
Chi-square test.
Control subjects vs. all PAH.
Unaffected carriers vs. all PAH.